Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 3/20 | 0.36 |
| ▸ | GPR142 | Q7Z601 | 1/20 | 0.30 |
| ▸ | PPARG | P37231 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11208660 | 0.83 | PPARG (0.40) | MMEGPR142PPARG | |
| SCHEMBL11208659 | 0.83 | PPARG (0.40) | MMEGPR142PPARG | |
| SCHEMBL7357707 | 0.80 | PPARG (0.36) | PPARG | |
| SCHEMBL10425835 | 0.78 | MAPT (0.35) | — | |
| SCHEMBL10845741 | 0.78 | CYP2C19 (0.36) | — | |
| SCHEMBL497463 | 0.78 | CYP2C19 (0.36) | — | |
| SCHEMBL10426034 | 0.78 | MAPT (0.35) | — | |
| SCHEMBL8772935 | 0.77 | FPR2 (0.44) | PPARG | |
| Methane SCHEMBL28061561 | 0.77 | CYP2C19 (0.35) | — | |
| SCHEMBL8772938 | 0.77 | FPR2 (0.44) | PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3546066-B1 | AMPHOTERIC DISSOCIATION ION EXCHANGE MEDIUM, ITS USE, AND SEPARATION CAPACITY CALIBRATION METHOD | CHONGQING BOLANYING BLY BIOTECHNOLOGY CO LTD CHINA (CN) | 2021-01-20 | — | — | EP | claimed |
| US-20190291095-A1 | AMPHOTERIC DISSOCIATION ION EXCHANGE MEDIUM AND USES THEREOF AND METHOD FOR CALIBRATING SEPARATION CAPACITY THEREOF | CHONGQING BOLANYING BLY BIOTECHNOLOGY CO LTD (CN) | 2019-09-26 | — | — | US | claimed |
| US-20090227597-A1 | PYRAZOLOPYRIMIDINONES AS PHOSPHODIESTERASE INHIBITORS | CTG PHARMA S.R.L. (IT) | 2009-09-10 | — | — | US | claimed |
| US-11358136-B2 | Amphoteric dissociation ion exchange medium and uses thereof and method for calibrating separation capacity thereof | CHONGQING BOLANYING (BLY) BIOTECHNOLOGY CO., LTD. (CN) | 2022-06-14 | — | — | US | disclosed |
| EP-3546066-B1 | AMPHOTERIC DISSOCIATION ION EXCHANGE MEDIUM, ITS USE, AND SEPARATION CAPACITY CALIBRATION METHOD | CHONGQING BOLANYING BLY BIOTECHNOLOGY CO LTD CHINA (CN) | 2021-01-20 | — | — | EP | disclosed |
| US-20200376480-A1 | AMPHOTERIC DISSOCIATION ION EXCHANGE MEDIUM AND USES THEREOF AND METHOD FOR CALIBRATING SEPARATION CAPACITY THEREOF | CHONGQING BOLANYING (BLY) BIOTECHNOLOGY CO., LTD. (CN) | 2020-12-03 | — | — | US | disclosed |
| EP-3546066-A1 | AMPHOTERIC DISSOCIATION ION EXCHANGE MEDIUM, APPLICATION METHOD, AND SEPARATION CAPACITY CALIBRATION METHOD | Chongqing Bolanying (BLY) Biotechnology Co., Ltd., China (CN) | 2019-10-02 | — | — | EP | disclosed |
| US-20190291095-A1 | AMPHOTERIC DISSOCIATION ION EXCHANGE MEDIUM AND USES THEREOF AND METHOD FOR CALIBRATING SEPARATION CAPACITY THEREOF | CHONGQING BOLANYING BLY BIOTECHNOLOGY CO LTD (CN) | 2019-09-26 | — | — | US | disclosed |
| CN-108097336-B | Both sexes dissociating ions exchange media, application method and separation capacity scaling method | 重庆博蓝鹰生物技术有限公司 | 2019-02-26 | — | — | CN | disclosed |
| CN-108097336-A | Both sexes dissociating ions exchange media, application process and separation capacity scaling method | 重庆博蓝鹰生物技术有限公司 | 2018-06-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090227597-A1 | PYRAZOLOPYRIMIDINONES AS PHOSPHODIESTERASE INHIBITORS | PDE3A, PDE3B, PDE2A | MME 4270/4885GPR142 96/4885PPARG 1501/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.